NTRA
Natera Inc

2,270
Mkt Cap
$27.39B
Volume
2.71M
52W High
$203.23
52W Low
$125.38
PE Ratio
-104.97
NTRA Fundamentals
Price
$200.86
Prev Close
$198.48
Open
$186.28
50D MA
$177.75
Beta
1.28
Avg. Volume
1.15M
EPS (Annual)
-$1.53
P/B
21.92
Rev/Employee
$382,704.33
Loading...
Loading...
News
all
press releases
Natera (NASDAQ:NTRA) Given New $190.00 Price Target at Wells Fargo & Company
Wells Fargo & Company lifted their price objective on Natera from $175.00 to $190.00 and gave the company an "equal weight" rating in a report on Friday...
MarketBeat·6h ago
News Placeholder
More News
News Placeholder
Natera (NASDAQ:NTRA) Price Target Raised to $250.00 at Canaccord Genuity Group
Canaccord Genuity Group raised their target price on Natera from $200.00 to $250.00 and gave the stock a "buy" rating in a research report on Friday...
MarketBeat·7h ago
News Placeholder
JPMorgan Chase & Co. Issues Positive Forecast for Natera (NASDAQ:NTRA) Stock Price
JPMorgan Chase & Co. boosted their target price on Natera from $210.00 to $240.00 and gave the stock an "overweight" rating in a research note on Friday...
MarketBeat·7h ago
News Placeholder
Natera (NASDAQ:NTRA) Price Target Raised to $250.00 at Evercore ISI
Evercore ISI boosted their price target on Natera from $190.00 to $250.00 and gave the stock an "outperform" rating in a research note on Friday...
MarketBeat·10h ago
News Placeholder
Barclays Issues Positive Forecast for Natera (NASDAQ:NTRA) Stock Price
Barclays upped their target price on shares of Natera from $210.00 to $230.00 and gave the stock an "overweight" rating in a research note on Friday...
MarketBeat·10h ago
News Placeholder
Natera (NASDAQ:NTRA) Price Target Raised to $230.00
BTIG Research lifted their target price on shares of Natera from $210.00 to $230.00 and gave the company a "buy" rating in a research note on Friday...
MarketBeat·13h ago
News Placeholder
Natera, Inc. $NTRA Shares Sold by Bank of New York Mellon Corp
Bank of New York Mellon Corp reduced its position in Natera, Inc. (NASDAQ:NTRA - Free Report) by 25.2% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 700,359...
MarketBeat·20h ago
News Placeholder
Here's What Key Metrics Tell Us About Natera (NTRA) Q3 Earnings
While the top- and bottom-line numbers for Natera (NTRA) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·2d ago
News Placeholder
Natera (NTRA) Reports Q3 Loss, Beats Revenue Estimates
Natera (NTRA) delivered earnings and revenue surprises of -64.10% and +15.77%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2d ago
News Placeholder
Natera Reports Third Quarter 2025 Financial Results
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today reported its financial results for the third quarter ended September 30, 2025. Recent Financial Highlights...
Business Wire·2d ago

Latest NTRA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.